LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 91.27 | 84.90 | 670 | 7420 | 0.0903 | 0.3776 | MN20160318_Q02 | H18 |
MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 91.27 | 84.90 | 7401 | 7420 | 0.9974 | 0.9992 | MN20160318_Q02 | H18 |
MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 92.98 | 84.90 | 2048 | 7257 | 0.2822 | 0.6422 | MN20160318_Q02 | C03 |
MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 92.98 | 84.90 | 4797 | 7257 | 0.6610 | 0.8750 | MN20160318_Q02 | C03 |
MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 92.98 | 84.90 | 654 | 7257 | 0.0901 | 0.3746 | MN20160318_Q02 | H18 |
MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 92.98 | 84.90 | 7577 | 7257 | 1.0440 | 1.0135 | MN20160318_Q02 | H18 |
MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 94.68 | 84.90 | 1219 | 7000 | 0.1741 | 0.5198 | MN20160318_Q02 | C03 |
MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 94.68 | 84.90 | 4842 | 7000 | 0.6917 | 0.8875 | MN20160318_Q02 | C03 |
MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 94.68 | 84.90 | 627 | 7000 | 0.0896 | 0.3690 | MN20160318_Q02 | H18 |
MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 94.68 | 84.90 | 7846 | 7000 | 1.1208 | 1.0362 | MN20160318_Q02 | H18 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 2.66 | 84.90 | 1 | 285 | 0.0035 | -0.9209 | MN20160318_Q02 | C10 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 2.66 | 84.90 | 585 | 285 | 2.0473 | 2.0113 | MN20160318_Q02 | C10 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 2.66 | 84.90 | 1 | 285 | 0.0035 | -0.9209 | MN20160318_Q02 | J05 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 2.66 | 84.90 | 653 | 285 | 2.2853 | 2.2065 | MN20160318_Q02 | J05 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 2.66 | 84.90 | 1 | 285 | 0.0035 | -0.9209 | MN20160318_Q02 | N17 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 2.66 | 84.90 | 733 | 285 | 2.5653 | 2.4253 | MN20160318_Q02 | N17 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | C10 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 4.36 | 84.90 | 654 | 322 | 2.0275 | 1.8868 | MN20160318_Q02 | C10 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | J05 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 4.36 | 84.90 | 729 | 322 | 2.2600 | 2.0542 | MN20160318_Q02 | J05 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | N17 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 4.36 | 84.90 | 795 | 322 | 2.4646 | 2.1948 | MN20160318_Q02 | N17 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | C10 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 6.06 | 84.90 | 742 | 365 | 2.0304 | 1.7995 | MN20160318_Q02 | C10 |
MCF 10A-H2B-mCherry | Neratinib | 0.1 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | J05 |